Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 2, February

Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)]

Volume:10   Issue: 2
Pp: 88-88
Christopher Bachran and Hendrik Fuchs
DOI: 10.2174/138945009787354548
Published on: 01 March, 2012

Targeted Tumor Therapies at a Glance

Volume:10   Issue: 2
Pp: 89-93
H. Fuchs and C. Bachran
DOI: 10.2174/138945009787354557
Published on: 01 March, 2012

Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family

Volume:10   Issue: 2
Pp: 94-103
E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich
DOI: 10.2174/138945009787354593
Published on: 01 March, 2012

Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma

Volume:10   Issue: 2
Pp: 104-109
A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo
DOI: 10.2174/138945009787354539
Published on: 01 March, 2012

Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

Volume:10   Issue: 2
Pp: 110-117
B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop
DOI: 10.2174/138945009787354566
Published on: 01 March, 2012

Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen

Volume:10   Issue: 2
Pp: 118-125
U. Elsasser-Beile, P. Buhler and P. Wolf
DOI: 10.2174/138945009787354601
Published on: 01 March, 2012

Convection-Enhanced Delivery: Neurosurgical Issues

Volume:10   Issue: 2
Pp: 126-130
W. A. Hall
DOI: 10.2174/138945009787354575
Published on: 01 March, 2012

Reducing the Immunogenicity of Protein Therapeutics

Volume:10   Issue: 2
Pp: 131-139
Masanori Onda
DOI: 10.2174/138945009787354511
Published on: 01 March, 2012

Saponins as Tool for Improved Targeted Tumor Therapies

Volume:10   Issue: 2
Pp: 140-151
H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran
DOI: 10.2174/138945009787354584
Published on: 01 March, 2012

Targeting: The ADEPT Story So Far

Volume:10   Issue: 2
Pp: 152-157
K. D. Bagshawe
DOI: 10.2174/138945009787354520
Published on: 01 March, 2012

Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy

Volume:10   Issue: 2
Pp: 158-175
P. M. Deckert
DOI: 10.2174/138945009787354502
Published on: 01 March, 2012